These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28486098)

  • 1. Preparation of
    Westrøm S; Generalov R; Bønsdorff TB; Larsen RH
    Nucl Med Biol; 2017 Aug; 51():1-9. PubMed ID: 28486098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of separation technology for the removal of radium-223 from targeted thorium conjugate formulations. Part I: purification of decayed thorium-227 on cation exchange columns.
    Frenvik JO; Dyrstad K; Kristensen S; Ryan OB
    Drug Dev Ind Pharm; 2017 Feb; 43(2):225-233. PubMed ID: 27628177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methodology for labeling proteins and peptides with lead-212 (212Pb).
    Baidoo KE; Milenic DE; Brechbiel MW
    Nucl Med Biol; 2013 Jul; 40(5):592-9. PubMed ID: 23602604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of separation technology for the removal of radium-223 from decayed thorium-227 in drug formulations. Material screening and method development.
    Frenvik JO; Kristensen S; Ryan OB
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1215-24. PubMed ID: 26569601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of separation technology for the removal of radium-223 from targeted thorium conjugate formulations. Part II: purification of targeted thorium conjugates on cation exchange columns.
    Frenvik JO; Dyrstad K; Kristensen S; Ryan OB
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1440-1449. PubMed ID: 28402142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiochemical separation of
    Pruszyński M; Walczak R; Rodak M; Bruchertseifer F; Morgenstern A; Bilewicz A
    Appl Radiat Isot; 2021 Jun; 172():109655. PubMed ID: 33657491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pb-214/Bi-214-TCMC-Trastuzumab inhibited growth of ovarian cancer in preclinical mouse models.
    Metebi A; Kauffman N; Xu L; Singh SK; Nayback C; Fan J; Johnson N; Diemer J; Grimm T; Zamiara M; Zinn KR
    Front Chem; 2023; 11():1322773. PubMed ID: 38333550
    [No Abstract]   [Full Text] [Related]  

  • 8. In situ Generated
    Stenberg VY; Juzeniene A; Bruland ØS; Larsen RH
    Curr Radiopharm; 2020; 13(2):130-141. PubMed ID: 32389119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (212)Pb-radioimmunotherapy induces G(2) cell-cycle arrest and delays DNA damage repair in tumor xenografts in a model for disseminated intraperitoneal disease.
    Yong KJ; Milenic DE; Baidoo KE; Brechbiel MW
    Mol Cancer Ther; 2012 Mar; 11(3):639-48. PubMed ID: 22238365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted alpha therapy with the
    Tornes AJK; Stenberg VY; Larsen RH; Bruland ØS; Revheim ME; Juzeniene A
    Front Med (Lausanne); 2022; 9():1058863. PubMed ID: 36507500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Alpha Therapy with Thorium-227.
    Frantellizzi V; Cosma L; Brunotti G; Pani A; Spanu A; Nuvoli S; De Cristofaro F; Civitelli L; De Vincentis G
    Cancer Biother Radiopharm; 2020 Aug; 35(6):437-445. PubMed ID: 31967907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor Activity of Novel Bone-seeking, α-emitting
    Juzeniene A; Bernoulli J; Suominen M; Halleen J; Larsen RH
    Anticancer Res; 2018 Apr; 38(4):1947-1955. PubMed ID: 29599310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A reverse
    Mastren T; Akin A; Copping R; Brugh M; Wilbur DS; Birnbaum ER; Nortier FM; John KD; Fassbender ME
    Nucl Med Biol; 2020; 90-91():69-73. PubMed ID: 33068963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Experimental Generator for Production of High-Purity
    Li RG; Stenberg VY; Larsen RH
    J Nucl Med; 2023 Jan; 64(1):173-176. PubMed ID: 35798556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cherenkov light production from the α-emitting decay chains of
    Wood V; Ackerman NL
    Appl Radiat Isot; 2016 Dec; 118():354-360. PubMed ID: 27771446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual targeting with
    Juzeniene A; Stenberg VY; Bruland ØS; Revheim ME; Larsen RH
    Front Med (Lausanne); 2022; 9():1051825. PubMed ID: 36733936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD46 targeted
    Li J; Huang T; Hua J; Wang Q; Su Y; Chen P; Bidlingmaier S; Li A; Xie Z; Bidkar AP; Shen S; Shi W; Seo Y; Flavell RR; Gioeli D; Dreicer R; Li H; Liu B; He J
    J Exp Clin Cancer Res; 2023 Mar; 42(1):61. PubMed ID: 36906664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanozeolite bioconjugates labeled with
    Piotrowska A; Męczyńska-Wielgosz S; Majkowska-Pilip A; Koźmiński P; Wójciuk G; Cędrowska E; Bruchertseifer F; Morgenstern A; Kruszewski M; Bilewicz A
    Nucl Med Biol; 2017 Apr; 47():10-18. PubMed ID: 28043005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Precision Oncology: Targeted Thorium-227 Conjugates As a New Modality in Targeted Alpha Therapy.
    Hagemann UB; Wickstroem K; Hammer S; Bjerke RM; Zitzmann-Kolbe S; Ryan OB; Karlsson J; Scholz A; Hennekes H; Mumberg D; Cuthbertson AS
    Cancer Biother Radiopharm; 2020 Sep; 35(7):497-510. PubMed ID: 32255671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose escalation and dosimetry of first-in-human α radioimmunotherapy with 212Pb-TCMC-trastuzumab.
    Meredith R; Torgue J; Shen S; Fisher DR; Banaga E; Bunch P; Morgan D; Fan J; Straughn JM
    J Nucl Med; 2014 Oct; 55(10):1636-42. PubMed ID: 25157044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.